Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 79,936 | reported | 16 Apr 2026 | tx 61+588,989−30,010 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Apr 2026 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 23,116 | 0.00 USD | |
| 16 Apr 2026 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 79,936 | 0.00 USD | deriv |
| 02 Mar 2026 | TAX_WITHHOLDING | Ultragenyx Pharmaceutical Inc. | 999 | 23.39 USD | |
| 01 Mar 2026 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 11,137 | 0.00 USD | |
| 01 Mar 2025 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 18,443 | 0.00 USD | |
| 01 Mar 2025 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 14,494 | 0.00 USD | |
| 03 Mar 2025 | TAX_WITHHOLDING | Ultragenyx Pharmaceutical Inc. | 1,348 | 42.92 USD | |
| 01 Mar 2025 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 26,074 | 0.00 USD | deriv |
| 01 Mar 2024 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 17,800 | 0.00 USD | |
| 01 Mar 2024 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 957 | 0.00 USD | |
| 01 Mar 2024 | TAX_WITHHOLDING | Ultragenyx Pharmaceutical Inc. | 470 | 53.69 USD | |
| 01 Mar 2024 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 31,400 | 0.00 USD | deriv |
| 01 Mar 2023 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 22,000 | 0.00 USD | |
| 01 Mar 2023 | SALE | Ultragenyx Pharmaceutical Inc. | 389 | 45.65 USD | |
| 01 Mar 2023 | OTHER | Ultragenyx Pharmaceutical Inc. | 10,599 | 45.65 USD | |
| 01 Mar 2023 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 2,663 | 0.00 USD | |
| 01 Mar 2023 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 39,400 | 0.00 USD | deriv |
| 01 Mar 2022 | SALE | Ultragenyx Pharmaceutical Inc. | 3,234 | 66.62 USD | |
| 01 Mar 2022 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 14,000 | 0.00 USD | |
| 01 Mar 2022 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 24,900 | 0.00 USD | deriv |
| 14 Oct 2021 | SALE | Ultragenyx Pharmaceutical Inc. | 358 | 81.14 USD | |
| 06 May 2021 | SALE | Ultragenyx Pharmaceutical Inc. | 363 | 113.68 USD | |
| 01 Mar 2021 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 4,636 | 0.00 USD | |
| 01 Mar 2021 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 5,500 | 0.00 USD | |
| 01 Mar 2021 | SALE | Ultragenyx Pharmaceutical Inc. | 4,255 | 138.18 USD |